Capstone Investment Advisors, LLC Aerie Pharmaceuticals Inc Transaction History
Capstone Investment Advisors, LLC
- $30.4 Billion
- Q3 2024
A detailed history of Capstone Investment Advisors, LLC transactions in Aerie Pharmaceuticals Inc stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 21,400 shares of AERI stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,400Holding current value
$0% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding AERI
# of Institutions
3Shares Held
2.4MCall Options Held
0Put Options Held
0About AERIE PHARMACEUTICALS INC
- Ticker AERI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,390,500
- Description
- Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...